{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:54:13Z","timestamp":1790146453898,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1136\/ard.60.12.1149","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:32:19Z","timestamp":1027765939000},"page":"1149-1151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Changes in the concentration and distribution of tissue factor pathway inhibitor in Beh\u00e7et's disease and systemic lupus erythematosus: effect on the prethrombotic state"],"prefix":"10.1016","volume":"60","author":[{"given":"I\u02d9","family":"Ertenli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kiraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u02d9","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u02d9 C","family":"Haznedaro\u01e7lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Erman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"\u00c7alg\u00fcneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e","family":"Kirazli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.60.12.1149_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2796.1996.396853000.x","article-title":"Impaired haemostatic kinetics and endothelial function in Beh\u00e7et's disease.","volume":"240","author":"Haznedaro\u01e7lu","year":"1996","journal-title":"J Intern Med"},{"key":"10.1136\/ard.60.12.1149_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.1780390217","article-title":"Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis.","volume":"39","author":"Inoh","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.12.1149_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1055\/s-0038-1655981","article-title":"Anticoagulant properties of the vascular endothelium.","volume":"77","author":"Bombeli","year":"1997","journal-title":"Thromb Haemostas"},{"key":"10.1136\/ard.60.12.1149_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001721-199506001-00002","article-title":"Tissue factor pathway inhibitor and the current concept of blood coagulation.","volume":"6","author":"Broze","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1136\/ard.60.12.1149_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-2007-1001894","article-title":"Tissue factor pathway inhibitor.","volume":"20","author":"Novotny","year":"1994","journal-title":"Semin Thromb Hemostas"},{"key":"10.1136\/ard.60.12.1149_bib6","first-page":"303","article-title":"Tissue factor pathway inhibitor concentrations in cirrhotic patients with and without portal vein thrombosis.","volume":"92","author":"\u00d6ks\u00fczo\u01e7lu","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1136\/ard.60.12.1149_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0049-3848(88)90340-4","article-title":"Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).","volume":"50","author":"Sandset","year":"1988","journal-title":"Thromb Res"},{"key":"10.1136\/ard.60.12.1149_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00001721-199506001-00009","article-title":"Tissue factor pathway inhibitor: proposed heparin recognition region.","volume":"6","author":"Harenberg","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1136\/ard.60.12.1149_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0049-3848(00)00424-2","article-title":"Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.","volume":"101","author":"Vambergue","year":"2001","journal-title":"Thromb Res"},{"key":"10.1136\/ard.60.12.1149_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0167-5273(00)00345-4","article-title":"The effect of heparin on tissue factor and tissue factor pathway inhibitor in patients with acute myocardial infarction.","volume":"75","author":"Yamamoto","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1136\/ard.60.12.1149_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001721-200101000-00001","article-title":"Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases.","volume":"12","author":"Asakura","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1136\/ard.60.12.1149_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1646409","article-title":"Coagulation and fibrinolytic activity in Beh\u00e7et's disease.","volume":"66","author":"Hampton","year":"1991","journal-title":"Thromb Haemostas"},{"key":"10.1136\/ard.60.12.1149_bib13","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archopht.1985.01050070061030","article-title":"Plasminogen activator activity levels in patients with Beh\u00e7et's syndrome.","volume":"103","author":"Mishima","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1136\/ard.60.12.1149_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/ard.48.11.933","article-title":"Risk factors for thrombosis in lupus patients.","volume":"48","author":"Hasselaar","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.12.1149_bib15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-89-5-660","article-title":"The spectrum of vasculitis.","volume":"89","author":"Fauci","year":"1978","journal-title":"Ann Intern Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724433128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724433128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.60.12.1149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:32:33Z","timestamp":1736141553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724433128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0003496724433128"],"URL":"https:\/\/doi.org\/10.1136\/ard.60.12.1149","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in the concentration and distribution of tissue factor pathway inhibitor in Beh\u00e7et's disease and systemic lupus erythematosus: effect on the prethrombotic state","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.60.12.1149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}